nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A5—Dactinomycin—skin cancer	0.108	0.157	CbGbCtD
Clonidine—CYP1A2—Imiquimod—skin cancer	0.0859	0.125	CbGbCtD
Clonidine—CYP1A1—Dacarbazine—skin cancer	0.0807	0.118	CbGbCtD
Clonidine—ABCB1—Vismodegib—skin cancer	0.052	0.0758	CbGbCtD
Clonidine—CYP1A2—Vemurafenib—skin cancer	0.047	0.0685	CbGbCtD
Clonidine—CYP3A4—Imiquimod—skin cancer	0.045	0.0655	CbGbCtD
Clonidine—CYP3A4—Temozolomide—skin cancer	0.045	0.0655	CbGbCtD
Clonidine—CYP2D6—Vemurafenib—skin cancer	0.0388	0.0564	CbGbCtD
Clonidine—CYP1A2—Dacarbazine—skin cancer	0.0361	0.0525	CbGbCtD
Clonidine—CYP3A4—Vismodegib—skin cancer	0.0312	0.0454	CbGbCtD
Clonidine—ABCB1—Dactinomycin—skin cancer	0.0273	0.0398	CbGbCtD
Clonidine—CYP3A4—Vemurafenib—skin cancer	0.0246	0.0359	CbGbCtD
Clonidine—CYP3A5—Docetaxel—skin cancer	0.0217	0.0316	CbGbCtD
Clonidine—CYP1A2—Fluorouracil—skin cancer	0.0211	0.0308	CbGbCtD
Clonidine—ABCB1—Docetaxel—skin cancer	0.0141	0.0206	CbGbCtD
Clonidine—CYP3A4—Docetaxel—skin cancer	0.00846	0.0123	CbGbCtD
Clonidine—NISCH—Paclitaxel—Docetaxel—skin cancer	0.00505	1	CbGdCrCtD
Clonidine—NISCH—hair follicle—skin cancer	0.0025	0.0802	CbGeAlD
Clonidine—NISCH—nipple—skin cancer	0.00169	0.0544	CbGeAlD
Clonidine—SLC6A2—nerve—skin cancer	0.00154	0.0494	CbGeAlD
Clonidine—CYP1A1—skin epidermis—skin cancer	0.00137	0.044	CbGeAlD
Clonidine—SLC22A4—neck—skin cancer	0.00111	0.0356	CbGeAlD
Clonidine—SLC22A3—nipple—skin cancer	0.00102	0.0327	CbGeAlD
Clonidine—NISCH—mammalian vulva—skin cancer	0.000988	0.0318	CbGeAlD
Clonidine—ADRA1D—epithelium—skin cancer	0.000951	0.0306	CbGeAlD
Clonidine—ADRA2C—nipple—skin cancer	0.000773	0.0249	CbGeAlD
Clonidine—SLC22A5—nipple—skin cancer	0.00074	0.0238	CbGeAlD
Clonidine—SLC22A3—connective tissue—skin cancer	0.000722	0.0232	CbGeAlD
Clonidine—ADRA1D—female reproductive system—skin cancer	0.000706	0.0227	CbGeAlD
Clonidine—CYP1A2—nipple—skin cancer	0.000671	0.0216	CbGeAlD
Clonidine—CYP1A1—nipple—skin cancer	0.000662	0.0213	CbGeAlD
Clonidine—ADRA2A—nipple—skin cancer	0.000617	0.0198	CbGeAlD
Clonidine—ADRA1B—head—skin cancer	0.000603	0.0194	CbGeAlD
Clonidine—SLC22A3—mammalian vulva—skin cancer	0.000595	0.0191	CbGeAlD
Clonidine—ADRA1D—head—skin cancer	0.00059	0.019	CbGeAlD
Clonidine—SLC22A4—female reproductive system—skin cancer	0.00056	0.018	CbGeAlD
Clonidine—ADRA1A—epithelium—skin cancer	0.000546	0.0176	CbGeAlD
Clonidine—SLC22A3—female reproductive system—skin cancer	0.000509	0.0164	CbGeAlD
Clonidine—NISCH—lymph node—skin cancer	0.000495	0.0159	CbGeAlD
Clonidine—ABCB1—blood vessel—skin cancer	0.000475	0.0153	CbGeAlD
Clonidine—SLC22A5—skin of body—skin cancer	0.000474	0.0152	CbGeAlD
Clonidine—ADRA2C—mammalian vulva—skin cancer	0.000451	0.0145	CbGeAlD
Clonidine—CYP1A1—epithelium—skin cancer	0.000445	0.0143	CbGeAlD
Clonidine—SLC22A1—head—skin cancer	0.000445	0.0143	CbGeAlD
Clonidine—ADRA2A—connective tissue—skin cancer	0.000437	0.0141	CbGeAlD
Clonidine—SLC6A2—female reproductive system—skin cancer	0.000436	0.014	CbGeAlD
Clonidine—SLC22A3—head—skin cancer	0.000425	0.0137	CbGeAlD
Clonidine—Depression—Temozolomide—skin cancer	0.000424	0.00153	CcSEcCtD
Clonidine—CYP1A1—skin of body—skin cancer	0.000424	0.0136	CbGeAlD
Clonidine—Hepatitis—Dactinomycin—skin cancer	0.000422	0.00152	CcSEcCtD
Clonidine—ADRA1A—lymphoid tissue—skin cancer	0.000421	0.0135	CbGeAlD
Clonidine—Body temperature increased—Vemurafenib—skin cancer	0.00042	0.00152	CcSEcCtD
Clonidine—Urinary tract infection—Temozolomide—skin cancer	0.000414	0.00149	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000413	0.00149	CcSEcCtD
Clonidine—Insomnia—Imiquimod—skin cancer	0.00041	0.00148	CcSEcCtD
Clonidine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000409	0.00147	CcSEcCtD
Clonidine—Paraesthesia—Imiquimod—skin cancer	0.000407	0.00147	CcSEcCtD
Clonidine—Cardiac failure congestive—Docetaxel—skin cancer	0.000405	0.00146	CcSEcCtD
Clonidine—Dyspnoea—Imiquimod—skin cancer	0.000404	0.00146	CcSEcCtD
Clonidine—Somnolence—Imiquimod—skin cancer	0.000403	0.00145	CcSEcCtD
Clonidine—Alopecia—Bleomycin—skin cancer	0.0004	0.00144	CcSEcCtD
Clonidine—Erythema—Bleomycin—skin cancer	0.000394	0.00142	CcSEcCtD
Clonidine—Decreased appetite—Imiquimod—skin cancer	0.000394	0.00142	CcSEcCtD
Clonidine—Hypersensitivity—Vemurafenib—skin cancer	0.000391	0.00141	CcSEcCtD
Clonidine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000391	0.00141	CcSEcCtD
Clonidine—Fatigue—Imiquimod—skin cancer	0.00039	0.00141	CcSEcCtD
Clonidine—Pain—Imiquimod—skin cancer	0.000387	0.0014	CcSEcCtD
Clonidine—CYP1A1—mammalian vulva—skin cancer	0.000386	0.0124	CbGeAlD
Clonidine—Hepatitis—Temozolomide—skin cancer	0.000382	0.00138	CcSEcCtD
Clonidine—Urinary tract infection—Fluorouracil—skin cancer	0.000381	0.00138	CcSEcCtD
Clonidine—Asthenia—Vemurafenib—skin cancer	0.000381	0.00138	CcSEcCtD
Clonidine—Hypoaesthesia—Temozolomide—skin cancer	0.00038	0.00137	CcSEcCtD
Clonidine—Hallucination—Temozolomide—skin cancer	0.00038	0.00137	CcSEcCtD
Clonidine—Pruritus—Vemurafenib—skin cancer	0.000376	0.00136	CcSEcCtD
Clonidine—Lethargy—Docetaxel—skin cancer	0.000375	0.00135	CcSEcCtD
Clonidine—Alopecia—Dactinomycin—skin cancer	0.000373	0.00135	CcSEcCtD
Clonidine—Feeling abnormal—Imiquimod—skin cancer	0.000373	0.00135	CcSEcCtD
Clonidine—Gastrointestinal pain—Imiquimod—skin cancer	0.00037	0.00134	CcSEcCtD
Clonidine—SLC22A5—female reproductive system—skin cancer	0.00037	0.0119	CbGeAlD
Clonidine—Epistaxis—Fluorouracil—skin cancer	0.00037	0.00133	CcSEcCtD
Clonidine—Erythema—Dactinomycin—skin cancer	0.000368	0.00133	CcSEcCtD
Clonidine—Pain in extremity—Docetaxel—skin cancer	0.000367	0.00133	CcSEcCtD
Clonidine—Ill-defined disorder—Bleomycin—skin cancer	0.000366	0.00132	CcSEcCtD
Clonidine—SLC6A2—head—skin cancer	0.000365	0.0117	CbGeAlD
Clonidine—Diarrhoea—Vemurafenib—skin cancer	0.000363	0.00131	CcSEcCtD
Clonidine—ADRA2A—mammalian vulva—skin cancer	0.00036	0.0116	CbGeAlD
Clonidine—Urticaria—Imiquimod—skin cancer	0.00036	0.0013	CcSEcCtD
Clonidine—Body temperature increased—Imiquimod—skin cancer	0.000358	0.00129	CcSEcCtD
Clonidine—Abdominal pain—Imiquimod—skin cancer	0.000358	0.00129	CcSEcCtD
Clonidine—Eye disorder—Temozolomide—skin cancer	0.000357	0.00129	CcSEcCtD
Clonidine—Tinnitus—Temozolomide—skin cancer	0.000356	0.00129	CcSEcCtD
Clonidine—Malaise—Bleomycin—skin cancer	0.000356	0.00128	CcSEcCtD
Clonidine—Cardiac disorder—Temozolomide—skin cancer	0.000355	0.00128	CcSEcCtD
Clonidine—Rhinitis—Fluorouracil—skin cancer	0.000353	0.00127	CcSEcCtD
Clonidine—Dizziness—Vemurafenib—skin cancer	0.000351	0.00127	CcSEcCtD
Clonidine—Hypoaesthesia—Fluorouracil—skin cancer	0.00035	0.00126	CcSEcCtD
Clonidine—Angiopathy—Temozolomide—skin cancer	0.000347	0.00125	CcSEcCtD
Clonidine—Mediastinal disorder—Temozolomide—skin cancer	0.000344	0.00124	CcSEcCtD
Clonidine—Cough—Bleomycin—skin cancer	0.000344	0.00124	CcSEcCtD
Clonidine—Ill-defined disorder—Dactinomycin—skin cancer	0.000341	0.00123	CcSEcCtD
Clonidine—Liver function test abnormal—Docetaxel—skin cancer	0.000339	0.00122	CcSEcCtD
Clonidine—ADRA1A—head—skin cancer	0.000339	0.0109	CbGeAlD
Clonidine—Vomiting—Vemurafenib—skin cancer	0.000338	0.00122	CcSEcCtD
Clonidine—Alopecia—Temozolomide—skin cancer	0.000338	0.00122	CcSEcCtD
Clonidine—Chest pain—Bleomycin—skin cancer	0.000336	0.00121	CcSEcCtD
Clonidine—Orthostatic hypotension—Docetaxel—skin cancer	0.000335	0.00121	CcSEcCtD
Clonidine—Abdominal pain upper—Docetaxel—skin cancer	0.000335	0.00121	CcSEcCtD
Clonidine—Rash—Vemurafenib—skin cancer	0.000335	0.00121	CcSEcCtD
Clonidine—Mental disorder—Temozolomide—skin cancer	0.000335	0.00121	CcSEcCtD
Clonidine—Dermatitis—Vemurafenib—skin cancer	0.000335	0.00121	CcSEcCtD
Clonidine—Hypersensitivity—Imiquimod—skin cancer	0.000334	0.0012	CcSEcCtD
Clonidine—Headache—Vemurafenib—skin cancer	0.000333	0.0012	CcSEcCtD
Clonidine—Erythema—Temozolomide—skin cancer	0.000333	0.0012	CcSEcCtD
Clonidine—Breast disorder—Docetaxel—skin cancer	0.000332	0.0012	CcSEcCtD
Clonidine—Discomfort—Bleomycin—skin cancer	0.000332	0.0012	CcSEcCtD
Clonidine—Malaise—Dactinomycin—skin cancer	0.000332	0.0012	CcSEcCtD
Clonidine—CYP1A1—female reproductive system—skin cancer	0.000331	0.0106	CbGeAlD
Clonidine—Cramp muscle—Docetaxel—skin cancer	0.000331	0.00119	CcSEcCtD
Clonidine—Nasopharyngitis—Docetaxel—skin cancer	0.000328	0.00119	CcSEcCtD
Clonidine—SLC22A4—lymph node—skin cancer	0.000327	0.0105	CbGeAlD
Clonidine—Asthenia—Imiquimod—skin cancer	0.000325	0.00117	CcSEcCtD
Clonidine—Confusional state—Bleomycin—skin cancer	0.000324	0.00117	CcSEcCtD
Clonidine—ADRA2C—head—skin cancer	0.000323	0.0104	CbGeAlD
Clonidine—Oedema—Bleomycin—skin cancer	0.000322	0.00116	CcSEcCtD
Clonidine—Pruritus—Imiquimod—skin cancer	0.00032	0.00116	CcSEcCtD
Clonidine—Infection—Bleomycin—skin cancer	0.00032	0.00115	CcSEcCtD
Clonidine—Nausea—Vemurafenib—skin cancer	0.000315	0.00114	CcSEcCtD
Clonidine—Thrombocytopenia—Bleomycin—skin cancer	0.000315	0.00114	CcSEcCtD
Clonidine—Arrhythmia—Fluorouracil—skin cancer	0.000314	0.00113	CcSEcCtD
Clonidine—Vision blurred—Temozolomide—skin cancer	0.000313	0.00113	CcSEcCtD
Clonidine—Tremor—Temozolomide—skin cancer	0.000312	0.00112	CcSEcCtD
Clonidine—Alopecia—Fluorouracil—skin cancer	0.000311	0.00112	CcSEcCtD
Clonidine—Diarrhoea—Imiquimod—skin cancer	0.00031	0.00112	CcSEcCtD
Clonidine—Discomfort—Dactinomycin—skin cancer	0.000309	0.00112	CcSEcCtD
Clonidine—Ill-defined disorder—Temozolomide—skin cancer	0.000309	0.00111	CcSEcCtD
Clonidine—ADRA2A—female reproductive system—skin cancer	0.000308	0.00992	CbGeAlD
Clonidine—Anorexia—Bleomycin—skin cancer	0.000307	0.00111	CcSEcCtD
Clonidine—Erythema—Fluorouracil—skin cancer	0.000306	0.00111	CcSEcCtD
Clonidine—Agitation—Temozolomide—skin cancer	0.000306	0.0011	CcSEcCtD
Clonidine—Angioedema—Temozolomide—skin cancer	0.000304	0.0011	CcSEcCtD
Clonidine—Hypotension—Bleomycin—skin cancer	0.000301	0.00108	CcSEcCtD
Clonidine—Oedema—Dactinomycin—skin cancer	0.0003	0.00108	CcSEcCtD
Clonidine—Malaise—Temozolomide—skin cancer	0.0003	0.00108	CcSEcCtD
Clonidine—Dizziness—Imiquimod—skin cancer	0.0003	0.00108	CcSEcCtD
Clonidine—Infection—Dactinomycin—skin cancer	0.000298	0.00108	CcSEcCtD
Clonidine—SLC22A3—lymph node—skin cancer	0.000298	0.00958	CbGeAlD
Clonidine—Palpitations—Temozolomide—skin cancer	0.000294	0.00106	CcSEcCtD
Clonidine—Thrombocytopenia—Dactinomycin—skin cancer	0.000294	0.00106	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000293	0.00106	CcSEcCtD
Clonidine—Cough—Temozolomide—skin cancer	0.00029	0.00105	CcSEcCtD
Clonidine—Paraesthesia—Bleomycin—skin cancer	0.000289	0.00104	CcSEcCtD
Clonidine—Weight increased—Docetaxel—skin cancer	0.000289	0.00104	CcSEcCtD
Clonidine—Vision blurred—Fluorouracil—skin cancer	0.000289	0.00104	CcSEcCtD
Clonidine—Vomiting—Imiquimod—skin cancer	0.000288	0.00104	CcSEcCtD
Clonidine—Dyspnoea—Bleomycin—skin cancer	0.000287	0.00104	CcSEcCtD
Clonidine—Anorexia—Dactinomycin—skin cancer	0.000286	0.00103	CcSEcCtD
Clonidine—Rash—Imiquimod—skin cancer	0.000286	0.00103	CcSEcCtD
Clonidine—Dermatitis—Imiquimod—skin cancer	0.000285	0.00103	CcSEcCtD
Clonidine—Headache—Imiquimod—skin cancer	0.000284	0.00102	CcSEcCtD
Clonidine—Arthralgia—Temozolomide—skin cancer	0.000283	0.00102	CcSEcCtD
Clonidine—Anxiety—Temozolomide—skin cancer	0.000282	0.00102	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000281	0.00101	CcSEcCtD
Clonidine—Discomfort—Temozolomide—skin cancer	0.00028	0.00101	CcSEcCtD
Clonidine—Decreased appetite—Bleomycin—skin cancer	0.00028	0.00101	CcSEcCtD
Clonidine—Dry mouth—Temozolomide—skin cancer	0.000277	0.000999	CcSEcCtD
Clonidine—CYP1A1—head—skin cancer	0.000276	0.00889	CbGeAlD
Clonidine—Pain—Bleomycin—skin cancer	0.000275	0.000993	CcSEcCtD
Clonidine—Confusional state—Temozolomide—skin cancer	0.000274	0.000988	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000273	0.000987	CcSEcCtD
Clonidine—Oedema—Temozolomide—skin cancer	0.000271	0.000979	CcSEcCtD
Clonidine—Infection—Temozolomide—skin cancer	0.00027	0.000973	CcSEcCtD
Clonidine—Nausea—Imiquimod—skin cancer	0.000269	0.000971	CcSEcCtD
Clonidine—Epistaxis—Docetaxel—skin cancer	0.000267	0.000963	CcSEcCtD
Clonidine—Nervous system disorder—Temozolomide—skin cancer	0.000266	0.000961	CcSEcCtD
Clonidine—Thrombocytopenia—Temozolomide—skin cancer	0.000266	0.000959	CcSEcCtD
Clonidine—Feeling abnormal—Bleomycin—skin cancer	0.000265	0.000957	CcSEcCtD
Clonidine—Skin disorder—Temozolomide—skin cancer	0.000264	0.000951	CcSEcCtD
Clonidine—Hyperhidrosis—Temozolomide—skin cancer	0.000262	0.000947	CcSEcCtD
Clonidine—Chest pain—Fluorouracil—skin cancer	0.000261	0.000941	CcSEcCtD
Clonidine—Decreased appetite—Dactinomycin—skin cancer	0.000261	0.000941	CcSEcCtD
Clonidine—Fatigue—Dactinomycin—skin cancer	0.000259	0.000934	CcSEcCtD
Clonidine—Anorexia—Temozolomide—skin cancer	0.000259	0.000934	CcSEcCtD
Clonidine—Discomfort—Fluorouracil—skin cancer	0.000258	0.00093	CcSEcCtD
Clonidine—ADRA2A—head—skin cancer	0.000258	0.00829	CbGeAlD
Clonidine—Pain—Dactinomycin—skin cancer	0.000257	0.000926	CcSEcCtD
Clonidine—Urticaria—Bleomycin—skin cancer	0.000256	0.000922	CcSEcCtD
Clonidine—SLC6A2—lymph node—skin cancer	0.000255	0.00821	CbGeAlD
Clonidine—Rhinitis—Docetaxel—skin cancer	0.000255	0.000919	CcSEcCtD
Clonidine—Body temperature increased—Bleomycin—skin cancer	0.000254	0.000918	CcSEcCtD
Clonidine—Hepatitis—Docetaxel—skin cancer	0.000254	0.000917	CcSEcCtD
Clonidine—Hypoaesthesia—Docetaxel—skin cancer	0.000253	0.000912	CcSEcCtD
Clonidine—Confusional state—Fluorouracil—skin cancer	0.000252	0.00091	CcSEcCtD
Clonidine—Oedema—Fluorouracil—skin cancer	0.00025	0.000902	CcSEcCtD
Clonidine—Infection—Fluorouracil—skin cancer	0.000248	0.000897	CcSEcCtD
Clonidine—Feeling abnormal—Dactinomycin—skin cancer	0.000247	0.000892	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000247	0.000892	CcSEcCtD
Clonidine—Insomnia—Temozolomide—skin cancer	0.000245	0.000886	CcSEcCtD
Clonidine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000245	0.000886	CcSEcCtD
Clonidine—Nervous system disorder—Fluorouracil—skin cancer	0.000245	0.000885	CcSEcCtD
Clonidine—Thrombocytopenia—Fluorouracil—skin cancer	0.000245	0.000884	CcSEcCtD
Clonidine—Tachycardia—Fluorouracil—skin cancer	0.000244	0.000881	CcSEcCtD
Clonidine—Paraesthesia—Temozolomide—skin cancer	0.000244	0.000879	CcSEcCtD
Clonidine—CYP3A4—female reproductive system—skin cancer	0.000243	0.00781	CbGeAlD
Clonidine—Dyspnoea—Temozolomide—skin cancer	0.000242	0.000873	CcSEcCtD
Clonidine—Somnolence—Temozolomide—skin cancer	0.000241	0.000871	CcSEcCtD
Clonidine—CYP2D6—female reproductive system—skin cancer	0.000239	0.00768	CbGeAlD
Clonidine—Anorexia—Fluorouracil—skin cancer	0.000238	0.00086	CcSEcCtD
Clonidine—Eye disorder—Docetaxel—skin cancer	0.000237	0.000857	CcSEcCtD
Clonidine—Abdominal pain—Dactinomycin—skin cancer	0.000237	0.000856	CcSEcCtD
Clonidine—Body temperature increased—Dactinomycin—skin cancer	0.000237	0.000856	CcSEcCtD
Clonidine—Hypersensitivity—Bleomycin—skin cancer	0.000237	0.000855	CcSEcCtD
Clonidine—Decreased appetite—Temozolomide—skin cancer	0.000236	0.000851	CcSEcCtD
Clonidine—Cardiac disorder—Docetaxel—skin cancer	0.000236	0.000851	CcSEcCtD
Clonidine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000234	0.000846	CcSEcCtD
Clonidine—Fatigue—Temozolomide—skin cancer	0.000234	0.000844	CcSEcCtD
Clonidine—Hypotension—Fluorouracil—skin cancer	0.000234	0.000843	CcSEcCtD
Clonidine—Pain—Temozolomide—skin cancer	0.000232	0.000838	CcSEcCtD
Clonidine—Constipation—Temozolomide—skin cancer	0.000232	0.000838	CcSEcCtD
Clonidine—ABCB1—epithelium—skin cancer	0.000231	0.00744	CbGeAlD
Clonidine—Asthenia—Bleomycin—skin cancer	0.000231	0.000833	CcSEcCtD
Clonidine—Angiopathy—Docetaxel—skin cancer	0.000231	0.000832	CcSEcCtD
Clonidine—Mediastinal disorder—Docetaxel—skin cancer	0.000229	0.000826	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000228	0.000822	CcSEcCtD
Clonidine—Pruritus—Bleomycin—skin cancer	0.000228	0.000821	CcSEcCtD
Clonidine—Arrhythmia—Docetaxel—skin cancer	0.000227	0.000819	CcSEcCtD
Clonidine—Insomnia—Fluorouracil—skin cancer	0.000226	0.000816	CcSEcCtD
Clonidine—ADRA2C—lymph node—skin cancer	0.000226	0.00727	CbGeAlD
Clonidine—Paraesthesia—Fluorouracil—skin cancer	0.000225	0.00081	CcSEcCtD
Clonidine—Alopecia—Docetaxel—skin cancer	0.000225	0.00081	CcSEcCtD
Clonidine—Feeling abnormal—Temozolomide—skin cancer	0.000224	0.000807	CcSEcCtD
Clonidine—Dyspnoea—Fluorouracil—skin cancer	0.000223	0.000805	CcSEcCtD
Clonidine—Mental disorder—Docetaxel—skin cancer	0.000223	0.000803	CcSEcCtD
Clonidine—Somnolence—Fluorouracil—skin cancer	0.000222	0.000802	CcSEcCtD
Clonidine—Gastrointestinal pain—Temozolomide—skin cancer	0.000222	0.000801	CcSEcCtD
Clonidine—Erythema—Docetaxel—skin cancer	0.000221	0.000798	CcSEcCtD
Clonidine—Hypersensitivity—Dactinomycin—skin cancer	0.000221	0.000798	CcSEcCtD
Clonidine—Decreased appetite—Fluorouracil—skin cancer	0.000217	0.000784	CcSEcCtD
Clonidine—SLC22A5—lymph node—skin cancer	0.000217	0.00696	CbGeAlD
Clonidine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000216	0.000779	CcSEcCtD
Clonidine—Urticaria—Temozolomide—skin cancer	0.000216	0.000778	CcSEcCtD
Clonidine—Asthenia—Dactinomycin—skin cancer	0.000215	0.000777	CcSEcCtD
Clonidine—Body temperature increased—Temozolomide—skin cancer	0.000215	0.000774	CcSEcCtD
Clonidine—Abdominal pain—Temozolomide—skin cancer	0.000215	0.000774	CcSEcCtD
Clonidine—Pain—Fluorouracil—skin cancer	0.000214	0.000772	CcSEcCtD
Clonidine—Muscle spasms—Docetaxel—skin cancer	0.000213	0.000767	CcSEcCtD
Clonidine—Feeling abnormal—Fluorouracil—skin cancer	0.000206	0.000744	CcSEcCtD
Clonidine—Diarrhoea—Dactinomycin—skin cancer	0.000205	0.000741	CcSEcCtD
Clonidine—Vomiting—Bleomycin—skin cancer	0.000205	0.000738	CcSEcCtD
Clonidine—Rash—Bleomycin—skin cancer	0.000203	0.000732	CcSEcCtD
Clonidine—Dermatitis—Bleomycin—skin cancer	0.000203	0.000731	CcSEcCtD
Clonidine—ABCB1—mammalian vulva—skin cancer	0.000201	0.00645	CbGeAlD
Clonidine—Hypersensitivity—Temozolomide—skin cancer	0.0002	0.000722	CcSEcCtD
Clonidine—CYP2D6—head—skin cancer	0.0002	0.00642	CbGeAlD
Clonidine—Urticaria—Fluorouracil—skin cancer	0.000199	0.000717	CcSEcCtD
Clonidine—Syncope—Docetaxel—skin cancer	0.000198	0.000716	CcSEcCtD
Clonidine—Body temperature increased—Fluorouracil—skin cancer	0.000198	0.000713	CcSEcCtD
Clonidine—Palpitations—Docetaxel—skin cancer	0.000195	0.000705	CcSEcCtD
Clonidine—Asthenia—Temozolomide—skin cancer	0.000195	0.000703	CcSEcCtD
Clonidine—Loss of consciousness—Docetaxel—skin cancer	0.000194	0.000701	CcSEcCtD
Clonidine—CYP1A1—lymph node—skin cancer	0.000194	0.00622	CbGeAlD
Clonidine—Cough—Docetaxel—skin cancer	0.000193	0.000696	CcSEcCtD
Clonidine—Pruritus—Temozolomide—skin cancer	0.000192	0.000693	CcSEcCtD
Clonidine—Nausea—Bleomycin—skin cancer	0.000191	0.00069	CcSEcCtD
Clonidine—Vomiting—Dactinomycin—skin cancer	0.000191	0.000689	CcSEcCtD
Clonidine—Rash—Dactinomycin—skin cancer	0.000189	0.000683	CcSEcCtD
Clonidine—Arthralgia—Docetaxel—skin cancer	0.000188	0.000679	CcSEcCtD
Clonidine—Chest pain—Docetaxel—skin cancer	0.000188	0.000679	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000187	0.000675	CcSEcCtD
Clonidine—Diarrhoea—Temozolomide—skin cancer	0.000186	0.00067	CcSEcCtD
Clonidine—Hypersensitivity—Fluorouracil—skin cancer	0.000184	0.000665	CcSEcCtD
Clonidine—Dry mouth—Docetaxel—skin cancer	0.000184	0.000665	CcSEcCtD
Clonidine—Confusional state—Docetaxel—skin cancer	0.000182	0.000657	CcSEcCtD
Clonidine—Oedema—Docetaxel—skin cancer	0.000181	0.000651	CcSEcCtD
Clonidine—ADRA2A—lymph node—skin cancer	0.00018	0.0058	CbGeAlD
Clonidine—Dizziness—Temozolomide—skin cancer	0.000179	0.000648	CcSEcCtD
Clonidine—Infection—Docetaxel—skin cancer	0.000179	0.000647	CcSEcCtD
Clonidine—Nausea—Dactinomycin—skin cancer	0.000178	0.000643	CcSEcCtD
Clonidine—ABCB1—lymphoid tissue—skin cancer	0.000178	0.00573	CbGeAlD
Clonidine—Shock—Docetaxel—skin cancer	0.000178	0.000641	CcSEcCtD
Clonidine—Nervous system disorder—Docetaxel—skin cancer	0.000177	0.000639	CcSEcCtD
Clonidine—Pruritus—Fluorouracil—skin cancer	0.000177	0.000638	CcSEcCtD
Clonidine—Thrombocytopenia—Docetaxel—skin cancer	0.000177	0.000638	CcSEcCtD
Clonidine—Tachycardia—Docetaxel—skin cancer	0.000176	0.000636	CcSEcCtD
Clonidine—Skin disorder—Docetaxel—skin cancer	0.000175	0.000633	CcSEcCtD
Clonidine—Vomiting—Temozolomide—skin cancer	0.000173	0.000623	CcSEcCtD
Clonidine—Anorexia—Docetaxel—skin cancer	0.000172	0.000621	CcSEcCtD
Clonidine—ABCB1—female reproductive system—skin cancer	0.000172	0.00553	CbGeAlD
Clonidine—Rash—Temozolomide—skin cancer	0.000171	0.000618	CcSEcCtD
Clonidine—Diarrhoea—Fluorouracil—skin cancer	0.000171	0.000617	CcSEcCtD
Clonidine—Dermatitis—Temozolomide—skin cancer	0.000171	0.000617	CcSEcCtD
Clonidine—Headache—Temozolomide—skin cancer	0.00017	0.000614	CcSEcCtD
Clonidine—Hypotension—Docetaxel—skin cancer	0.000169	0.000609	CcSEcCtD
Clonidine—Dizziness—Fluorouracil—skin cancer	0.000165	0.000597	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000164	0.000593	CcSEcCtD
Clonidine—Insomnia—Docetaxel—skin cancer	0.000163	0.000589	CcSEcCtD
Clonidine—Paraesthesia—Docetaxel—skin cancer	0.000162	0.000585	CcSEcCtD
Clonidine—Nausea—Temozolomide—skin cancer	0.000161	0.000582	CcSEcCtD
Clonidine—Dyspnoea—Docetaxel—skin cancer	0.000161	0.000581	CcSEcCtD
Clonidine—Somnolence—Docetaxel—skin cancer	0.00016	0.000579	CcSEcCtD
Clonidine—Vomiting—Fluorouracil—skin cancer	0.000159	0.000574	CcSEcCtD
Clonidine—Rash—Fluorouracil—skin cancer	0.000158	0.000569	CcSEcCtD
Clonidine—Dermatitis—Fluorouracil—skin cancer	0.000158	0.000568	CcSEcCtD
Clonidine—Decreased appetite—Docetaxel—skin cancer	0.000157	0.000566	CcSEcCtD
Clonidine—Headache—Fluorouracil—skin cancer	0.000157	0.000565	CcSEcCtD
Clonidine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000156	0.000562	CcSEcCtD
Clonidine—Fatigue—Docetaxel—skin cancer	0.000156	0.000562	CcSEcCtD
Clonidine—Constipation—Docetaxel—skin cancer	0.000154	0.000557	CcSEcCtD
Clonidine—Pain—Docetaxel—skin cancer	0.000154	0.000557	CcSEcCtD
Clonidine—Feeling abnormal—Docetaxel—skin cancer	0.000149	0.000537	CcSEcCtD
Clonidine—Nausea—Fluorouracil—skin cancer	0.000149	0.000536	CcSEcCtD
Clonidine—Gastrointestinal pain—Docetaxel—skin cancer	0.000148	0.000533	CcSEcCtD
Clonidine—ABCB1—head—skin cancer	0.000144	0.00462	CbGeAlD
Clonidine—Body temperature increased—Docetaxel—skin cancer	0.000143	0.000515	CcSEcCtD
Clonidine—Abdominal pain—Docetaxel—skin cancer	0.000143	0.000515	CcSEcCtD
Clonidine—Hypersensitivity—Docetaxel—skin cancer	0.000133	0.00048	CcSEcCtD
Clonidine—Asthenia—Docetaxel—skin cancer	0.00013	0.000467	CcSEcCtD
Clonidine—Pruritus—Docetaxel—skin cancer	0.000128	0.000461	CcSEcCtD
Clonidine—Diarrhoea—Docetaxel—skin cancer	0.000124	0.000446	CcSEcCtD
Clonidine—Dizziness—Docetaxel—skin cancer	0.000119	0.000431	CcSEcCtD
Clonidine—Vomiting—Docetaxel—skin cancer	0.000115	0.000414	CcSEcCtD
Clonidine—Rash—Docetaxel—skin cancer	0.000114	0.000411	CcSEcCtD
Clonidine—Dermatitis—Docetaxel—skin cancer	0.000114	0.00041	CcSEcCtD
Clonidine—Headache—Docetaxel—skin cancer	0.000113	0.000408	CcSEcCtD
Clonidine—Nausea—Docetaxel—skin cancer	0.000107	0.000387	CcSEcCtD
Clonidine—ABCB1—lymph node—skin cancer	0.000101	0.00323	CbGeAlD
